Kodiak Sciences Inc.

NASDAQ:KOD

Biotechnology

Healthcare
$97.81 -0.08%

-$0.03 today

Market cap
$6.40B
Beta
2.21
P/E (TTM)
-9.6
EPS (TTM)
-$3.73
52W Low $3.43High $47.84

Volume 0.74M

Average 1.10M

Returns on capital

Kodiak Sciences Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-146.1%

avg -47.3%

ROIC

-73.7%

avg -7.6%

ROA

-65.4%

avg -132.5%

Analysis

ROA is currently the strongest return metric at -65.4% versus its period average of -132.5%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Victor Perlroth

Co-Founder, Chairman, Chief Executive Officer & PresidentUSD 1.58M520<0.01%

John A. Borgeson

Executive Vice President, Chief Financial Officer & SecretaryUSD 937.16K63211.93K0.40%

Hong Liang

Senior Vice President of DevelopmentUSD 300.71K54130.17K0.25%

J. Pablo Velazquez-Martin

Chief Medical Officer————

Laurent Ducay

Senior Vice President of Biologics Development & Manufacturing————

Stephen Raillard

Senior Vice President of Chemical Development & Manufacturing————

Almas Qudrat

Chief Quality Officer————

Wayne To

Chief Technology Officer————

Dolly S. Chang

Chief Scientific Officer————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Oct 21, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

88

$241.33M

Sells

14

$4.92M

Net Transaction Value

+$236.41M

Net buying

Most Active

BAKER BROS. ADVISORS LP

88 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Nov 5, 26

BAKER BROS. ADVISORS LP

Indirect

Buy$463.3K
Nov 5, 26

BAKER BROS. ADVISORS LP

Indirect

Buy$8.1M
Nov 4, 26

BAKER BROS. ADVISORS LP

Indirect

Buy$861.2K
Nov 4, 26

BAKER BROS. ADVISORS LP

Indirect

Buy$15M
Oct 21, 26

BORGESON JOHN A.

Direct

Sell$273.9K
Oct 21, 26

BORGESON JOHN A.

Direct

Sell$187.4K
Oct 21, 26

BORGESON JOHN A.

Direct

Sell$9.5K
Oct 21, 26

BORGESON JOHN A.

Direct

Sell$746.4K
Oct 21, 26

BORGESON JOHN A.

Direct

Sell$149.6K
Oct 21, 26

BORGESON JOHN A.

Direct

Sell$684.1K

1–10 of 102

Summary

Insiders reported 88 buys worth $241.33M and 14 sells worth $4.92M over the last 12 months. That adds up to net buying of $236.41M. BAKER BROS. ADVISORS LP was the most active insider with 88 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/AN/A
N/A2 analysts
Net IncomeN/AN/AN/A
N/A2 analysts
EBITN/AN/AN/A
N/A2 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does Kodiak Sciences Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about KOD's management, answered from reported figures.

Who manages KOD?

Kodiak Sciences Inc. (KOD) lists 9 active executives. The top listed executive is J. Pablo Velazquez-Martin, Chief Medical Officer.

Are KOD insiders buying or selling?

Recent insider activity shows net buying of $266.33M.